Joint action on personalised cancer medicine kicks off

LIH contributes to ambitious EU project

The Luxembourg Research Clinic (LRC) and the LIH Department of Medical Informatics are contributing to the European Joint Action on Personalised Cancer Medicine, an extensive collaboration involving 29 countries and more than 140 partner organisations. Through practical pilot projects and the exchange of expertise, the initiative aims to improve cancer prevention, diagnosis, treatment and follow-up by adapting care to each patient’s individual profile. The LRC is helping to translate these innovative approaches into clinical practice, notably by supporting advanced diagnostics, tailored treatment strategies and the further development of Molecular Tumour Boards in Luxembourg.

Read the full article on the LIH website to discover the project’s activities and the partners involved.

More news & updates

Luxembourg Research Clinic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.